Awadhesh Kumar Singh

11PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsEndocrinologyHaematological tumoursTraditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial.

Awadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan

|Mar 12, 2024
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.

Subir Ray, Nitin Kapoor, Neeta Deshpande

|Jan 23, 2023
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.

Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh

|Nov 25, 2022
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.

Arjun Baidya, Asish Kumar Basu, Rana Bhattacharjee

|Aug 02, 2021
Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes.

Awadhesh K Singh, Ritu Singh, Partha Pratim Chakraborty

|Apr 01, 2021
Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction?

Awadhesh Kumar Singh, Ritu Singh, Anoop Misra

Pageof 2

Frequent Collaborators

5 joint publications

Ritu Singh

2 joint publications

Anoop Misra

2 joint publications

Akriti Singh

1 joint publications

Clare L Gillies